Form and Function: The Crystalens HDcrstodayeurope.com/wp-content/themes/crste/assets/... · 14 HD OPTICS: MYTHS AND FACTS Data-driven truths about the Crystalens accommodating IOL

Supplement to October 2009

Produced under an educationalgrant from Bausch & Lomb.

DataLink statistics and

clinical experience

from the Crystalens HD

users’ meeting.

Form and Function:

The Crystalens HD

Form and Function:

The Crystalens HDDataLink statistics and

clinical experience

from the Crystalens HD

users’ meeting.

CRSTeuro1009_SUPP_crysta.qxd 8/20/09 3:44 PM Page 1

2 I SUPPLEMENT TO CATARACT & REFRACTIVE SURGERY TODAY EUROPE I OCTOBER 2009

FORM AND FUNCTION: THE CRYSTALENS HD

Data and Insights forCrystalens Practitioners

Users’ meetings are a wealth of knowledge forsurgeons who implant the Crystalens accom-modating IOL platform (Bausch & Lomb,Rochester, New York). They give surgeons theopportunity to discuss with their colleagueswhat’s new and what’s working with these IOLs.

I had the pleasure of moderating the Crystalens users’meeting held in San Francisco, before the April ASCRSmeeting. At the users’ meeting, I polled the attendees ontheir clinical use of the Crystalens HD. One of the moreinteresting findings had to do with the correction of astig-matism. It seems that where and how surgeons choose totreat astigmatism largely depends on their access to tech-nology. Those who own an ambulatory surgery center(ASC), but not an excimer laser, prefer to use limbal relaxingincisions (LRIs), piggybacked IOL procedures, and refractivelens exchanges over LASIK or PRK for enhancements (Table1). Those who own an excimer laser, but not an ASC, per-form enhancements with a laser 100% of the time. Surgeonswho own both an ASC and an excimer laser favor usingLASIK or PRK over LRIs, refractive lens exchanges, and pig-gybacked IOLs to touch up postoperative patients.

Also, we learned that, according to Crystalens users’data tracked with DataLink (SurgiVision ConsultantsInc., Scottsdale, Arizona), the Crystalens HD is a highlypredictable premium refractive IOL compared withthree other presbyopia-correcting lenses.

The articles herein, based on the presentations from theSan Francisco meeting, discuss the quality of the CrystalensHD’s intermediate vision compared with that of multifocalIOLs, how time may affect refractive targeting, and the spe-cific effects of sphere and cylinder on visual quality with var-ious lenses. The authors provide many surgical pearls as well.

If you have not yet had the chance to attend a Crystalensusers’ meeting, you should. If not, this monograph is thenext best thing.

—Stephen G. Slade, MD

3 THE CRYSTALENS HD: A CLINICIAN’SPERSPECTIVEWhy I believe the Crystalens HD is the bestpremium IOL by any metric we cancurrently measure. BY RICHARD L. LINDSTROM, MD

6 TOP 10 HABITS OF THE SUCCESSFULCRYSTALENS SURGEONBY HARVEY L. CARTER, MD

7 RESULTS WITH THE CRYSTALENS HDDataLink measurements comparedagainst multifocal IOLs. BY GUY M. KEZIRIAN, MD

11 CRYSTALENS CLINICAL KEYSPearls I have learned from personal experiencewith the Crystalens accommodating IOL. BY UDAY DEVGAN, MD

14 HD OPTICS: MYTHS AND FACTSData-driven truths about the Crystalensaccommodating IOL. BY JOHN A. HOVANESIAN, MD

Contents

TABLE 1 . TRE ATING A STI GM ATI SM

■ LRIs, refractive lensexchanges, andpiggybacked IOLs

■ LASIK and PRK

If you own an ASC and anexcimer laser, which do youperform most often?

If you own an ASC, whichdo you perform most often?

38%

62%

64%

36%


OCTOBER 2009 I SUPPLEMENT TO CATARACT & REFRACTIVE SURGERY TODAY EUROPE I 3

The Crystalens HD:A Clinician’s Perspective

I have had 20 years of experience with multi-focal IOLs, but I have abandoned these lensesbecause I think accommodating IOLs are thefuture of intraocular surgery. This articleexplains why I prefer the Crystalens HD(Bausch & Lomb, Rochester, New York) over

multifocal IOLs. It also describes for whom the CrystalensHD works and how ophthalmologists can use it clinically.

THE CRYSTALENS HDThe Crystalens HD is a blended, bispheric, monofocal,

accommodating IOL. It delivers an excellent depth of focuswith a superior quality of vision compared with any multifo-cal IOL on the market. The Crystalens HD is based on thestandard Crystalens Five-O optic which, per the US Foodand Drug Administration’s (FDA’s) labeling,1 delivers an aver-age of 1.00 D of accommodative amplitude. The HD designadds a 1.5-mm–diameter circle of -0.045 µm of sphericalaberration to the optic’s central region. This central area isonly about 3 µm high, and it is tumble-polished (blended)to be imperceptible to the patient and to the surgeon at theslit lamp. Thus, although the Crystalens HD is not anaspheric lens, it has a degree of spherical aberration com-pared to the Five-O or a standard monofocal IOL. Having asmall amount of negative spherical aberration has beenproven optically beneficial.2

The Crystalens HD is not a multifocal implant; it gener-ates only one image. This monofocal design offers advan-tages in terms of near, intermediate, and distance acuities inaddition to significant accommodative amplitude.

WHY THE HD?The pupil gets smaller with age. Older patients’ pupils

dilate to only about 4 to 5 mm in a mesopic environmentand constrict to only 2 to 3 mm in bright light (Figure 1).3

The HD was created to give presbyopic patients better nearvisual acuity without sacrificing the Crystalens’ pseudopha-kic depth of focus, accommodative effect, or its distance orintermediate acuities.

My fellow, John Berdahl, MD, and I conducted a retro-spective study4 of the Crystalens Five-O and the HD inwhich we dilated patients, placed apertures in front of theireyes, and then compared their visual acuities and refractionsat maximum dilation and apertures of 4, 3, and 2 mm. IfCrystalens Five-O patients start with a 4-mm pupil and thenaccommodate -0.50 D to read in bright light, their visionshifts to 0.25 D. This is not ideal, although Five-O patientscan still read, because their accommodation overcomes theproblem. With the Crystalens HD, the pupil’s restrictionfrom 4 to 2 mm shifts its refraction from -0.25 to -0.50 D,which is better for reading.

Patients experience a myopic shift to blue light whendriving at night. In response, the HD lens shifts to a positiverefraction (comparatively, the Tecnis aspheric IOL [AbbottMedical Optics Inc., Santa Ana, California] remains in aboutthe same position). Because the HD enhances near vision asthe pupil constricts, its refractive target moves up to plano.

WHY I HAVE ABAND ONED MULTIFOCALIOL S FOR THE CRYSTALENS

Although I have implanted many patients with multifo-cal IOLs over the years and most of them are happy, I thinkthat visual quality is the surgeon’s No. 1 job, and I feel that

Why I believe the Crystalens HD is the best premium IOL

by any metric we can currently measure.

BY RICHARD L. LINDSTROM, MD

DataLink statistics and clinical experience from the Crystalens HD users’ meeting

Figure 1. Average pupil diameter by age. (Kornzweig AL.

Physiological effects of age on the visual process. Sight Sav

Rev.1954;24,130-138.)



the Crystalens HD’s aspheric monofocal design givespatients a slight edge in nighttime driving. Despite the argu-ment that an aspheric multifocal IOL provides better visionthan a spherical multifocal IOL, in fact, modulation transferfunction and contrast sensitivity with a 3-mm pupil is signif-icantly worse with a multifocal implant than with theCrystalens HD.5 The data show that 20/10 vision with anaspheric monofocal IOL is equal to 20/16 vision with a re-fractive multifocal lens. Modulation transfer functions alsoprove that the quality of the image generated is better withan aspheric monofocal than a multifocal design (Table 1).The reason is that two overlapping images reduce contrastsensitivity. Superimposing a focused image and a defocusedimage retains edge sharpness but reduces contrast.

Another reason I prefer the Crystalens HD to multifocalimplants is its reading distance. People do not like to holdreading material too close. Now that the AcrySof RestorIOL (Alcon Laboratories, Inc., Fort Worth, Texas) hasadopted a +3.00 D add, bringing the images closer togeth-er will reduce patients’ quality of vision and increase nightvision symptoms. Figures 2A and B are simulations by JackHolladay, MD, of Bellaire, Texas, of what patients will seethrough monofocal and multifocal lenses. Multifocal lens-es also distort color significantly (Figure 3), and adding a

blue-light–filtering chromophore to these lenses furtherreduces the quality of the color they transmit.

CLINICAL DATAIn the US FDA clinical trial, the Crystalens HD showed

better mesopic contrast sensitivity with and without glarethan the Five-O (Figure 4). My colleagues and I were sur-prised to find this improvement in distance vision in addi-tion to better near acuity with the HD. Thus, the CrystalensHD now provides two benefits in a mesopic environment: aslight myopic shift, which is good for countering presbyopia,and enhanced contrast sensitivity.

The Crystalens HD demonstrates a high quality of visionand excellent depth of focus. A comparison of distanceUVCA among the Crystalens HD, the Crystalens Five-O, theAcrySof ReSTOR +4.0 D, and the ReZoom IOLs shows thatthe HD surpasses every other lens (Figure 5A), a fact that Ithink clinical experience corroborates. The Crystalens HDalso showed improved performance at near compared withthe Five-O version of the lens (Figure 5B).


Figure 2. A simulation of vision while driving at night with (A) monofocal and (B) multifocal implants.

A B

Figure 3. Color control patches illustrate how different IOLs

distort color.

Resolution Efficiency

Lens Hi-Contr Resolution MTF 5%Efficiency Cut-off

Monofocal 20/10 83% 94%

AMO-Array 20/18 74% 56%

Pharmacia-Annular 20/15 66% 53%

3M Diffraction 20/16 83% 82%

Morcher-Diffraction 20/17 83% 84%

Wright Aspheric 20/14 74% 63%

TABLE 1. MULTIFOCAL IOL MTF COMPARISON

(Cou

rtesy

of Ja

ck T.

Holla

day,M

D)



DataLink figures from Guy Kezirian, MD, showed similarfindings. Of particular interest, the Crystalens HD almostmatched the AcrySof ReSTOR IOL +4.0 D in UCVA(20/29.4 vs 20/29, respectively; see Dr. Kezirian’s article onpage 7).

CLINIC AL PE ARL SI am confident that the indications for the Crystalens

HD are the same as for a monofocal aspheric IOL. Onlypatients who have high corneal spherical aberration, suchas those who have undergone hyperopic LASIK, may bepoor candidates for this lens. Likewise, the Crystalens HD issuitable for patients with glaucoma and age-related macu-lar degeneration, contrary to multifocal IOLs.

The Crystalens HD has only a few surgical requirementsfor optimal implantation. First, the capsulorrhexis shouldbe 5.5 to 6 mm and it should overlap the optic to hold its

position in the capsular bag. Because capsular fibrosis willdiminish accommodation, thorough cortical clean-up,capsular polishing, and the pre- and postoperative use oftopical NSAIDs, antibiotics, and steroids are recommend-ed. I also treat my patients with prednisolone acetate b.i.d.for 6 to 8 weeks postoperatively. I discontinue the steroidafter 4 to 6 weeks. To remove the viscoelastic, I use therock and roll technique described by Steve Arshinoff, MD.7

Finally, watertight wounds are mandatory to prevent infec-tion and any movement of the implant.

Other measures that will consistently optimize outcomesare a healthy ocular surface, a clear and open posterior cap-sule, a healthy macula, and less than 0.50 D of preoperativedefocus or astigmatism. Intraoperatively, Crystalens HDpatients see best when their refraction is within 0.50 D ofplano. Ideally, I try to set these patients’ distance eye a littlebit to the plus side and the near eye slightly negatively.


Figure 4. (A) The Crystalens HD showed no functionally significant loss of contrast sensitivity under mesopic conditions without

glare compared with the Crystalens AT-45 IOL.5,6 In fact, the Crystalens HD performed as well as or better than the Crystalens AT-

45 in low-light conditions.5 (B) Similarly, patients implanted with the HD IOL performed as well as or better than patients

implanted with the Crystalens AT-45 IOL in contrast sensitivity testing under low-light situations in the presence of glare.5,6

A B

Figure 5. The results from the Crystalens HD trial have been compared with a database of outcomes following implantation

with Crystalens Five-O, AcrySof Restor, and ReZoom (Abbott Medical Optics Inc.) IOLs.8,9 The Crystalens HD gave favorable

results in (A) monocular uncorrected distance visual acuity and (B) monocular uncorrected near visual acuity.8,9

A B



ENHANCE MENTSEnhancements are a fact of presbyopia-correcting IOLs;

even Nd:YAG capsulotomies are enhancements. Typicalenhancement rates range from 15% to 20% based on theaccuracy of the biometry, not the predictability of the lens.Because the performance of accommodating IOLs dependson the stability of the capsule, perform an Nd:YAG capsulo-tomy before an enhancement, then treat defocus with yourpreferred method (ie, an excimer laser, piggybacked IOL,refractive keratectomy, conductive keratoplasty). Our dataindicate that the Crystalens HD may in fact accommodate alittle better after a Nd:YAG laser capsulotomy, because themovement comes from constriction of the capsule’s sides,not its center. To enhance near acuity, every 0.50 D ofmyopia adds one line. However, I never target more than -1.00 D with the Crystalens HD. Smaller pupils enhance nearvision as well, so you can counsel your patients to brightenlights when reading (they can also use miotics). An opencapsule can also strengthen near vision. Finally, binocularsummation adds one line of acuity at all distances, which is

another reason for implanting in both eyes. Near acuitycontinues to improve out to 3 years with the Crystalens HD.Further, many patients will tolerate having to use readersoccasionally in exchange for all the benefits of this lens. ■

Richard L. Lindstrom, MD, is Founder and Attending Surgeonat Minnesota Eye Consultants, PA, in Bloomington. He is a paidconsultant to Alcon Laboratories, Inc., Abbott Medical Optics,Inc., and Bausch & Lomb. Dr. Lindstrom may be reached at tel:+1 612 813 3600; e-mail: [email protected].

1. Crystalens HD [package insert].Rochester,New York:Bausch & Lomb;2008.2. Packer M,Fine IH,Hoffman RS,Piers PA.Improved functional vision with a modified prolate intraocular lens. J Cataract Refract Surg.2004:30:986-992.3. Nakamura K,Bissen-Miyajima H,Oki S,Onuma K.Pupil sizes in different Japanese age groups and the implications for intraocularlens choice.J Cataract Refract Surg.2009;35(1):134-138.4. Berdhal JP,Davis EA,Samuelson TW,Lindstrom RL.Intraocular lens refractive power in differing optical zones of Crystalens HD andstandard monofocal lens using Ray Tracing.Paper presented at:The ASCRS Symposium on Cataract,IOL and Refractive Surgery;April5,2009;San Francisco,.5. Data on file with Bausch & Lomb;Rochester,New York.6. Hovanesian J,Chu R,Davies JA,et al.The new generation Crystalens better than the rest? Ophthalmology Times Europe.2008;4(1)7. Arshinoff S.Rock ‘n’Roll Removal of Healon GV.Video presented at:The American Society of Cataract and Refractive Surgery FilmFestival;.June 1-5,1996;Seattle,Washington.8. FDA Clinical Trial Data.9. Data on file with Datalink Surgivision;Scottsdale,Arizona.


BY HARVEY L. CARTER, MD

1. A total commitment to refractive lensimplant surgery. Success with presbyopia-cor-recting IOLs demands a full commitment of chairtime, staff training, proper equipment (new-gen-

eration phaco system, Nd:YAG laser), biometry (immersion A-scan, noncontact A-scan, IOL calculation formulae), outcomestracking (DataLink [SurgiVision Consultants Inc., Scottsdale,Arizona]), enhancement strategies (excimer laser, limbal relaxingincision [LRIs], piggyback IOLs), and quality improvement.

2. Obsessive preoperative measurements. It is not anoverstatement to say that surgeons adopting refractive IOLsneed to obsess over their preoperative measurements. My staffand I perform all of the following for each patient: manual ker-atometry, automated keratometry, immersion biometry,IOLMaster biometry (Carl Zeiss Meditec, Jena, Germany), andmultiple IOL calculations.

3. Thorough expectations management and accuraterefractive targeting. The refractive target with theCrystalens HD IOL is plano. Patients’ results have been nothingless than spectacular. Explain to patients that their near visionwill improve with time.

4. Fastidious attention to watertight incisions. My staffand I pay close attention to the wound closure at the end of

each surgery. For the paracentesis, I make what I call a pararadialincision. Instead of entering the knife on the radius of thecornea, I make a slightly diamond-shaped incision through thecornea, which seals much tighter with less hydration. I have alsoreverted to a fibrin-sealed near-clear corneal incision. I enter thesclera only slightly and then tunnel into the cornea with a metalblade.

5. Careful sizing of the capsulorrhexis. When implantingthe Crystalens HD, the capsulorhexis should be 5.5 to 6 mm orsmaller. Capsulotomies that are smaller than 5 mm will besmaller than the lens’ optic and may complicate the lens’implantation. Capsulotomies larger than 6.5 mm may cause thezonules to extend into the anterior capsule. Leave as much ofthe anterior capsule covering the plate haptics as possible, androtate the lens to achieve this if necessary.

6. Meticulous cortical clean-up. Residual cortical materi-al can interfere with the capsule’s healing or decenter thelens. Only vacuum the anterior capsule before implanting thelens if it can be done easily. Then, rotate the optic inside thebag to make sure there is no cortical material left around thebag’s edge.

7. Consistent positioning of the IOL. I position all IOLsvertically in routine cases, because I can easily identify problemsif they do not align. A vertical position also shows the

TOP 10 HABITS OF THE SUCCE SSFUL CRYSTALEN S SURGEON

(Continued on page 15)



Results With theCrystalens HD

SurgiVision DataLink IOL Edition(SurgiVision Consultants Inc., Scottsdale,Arizona) is a powerful online tool thatenables ophthalmic surgeons to track theiroutcomes and compare them against aglobal data set. DataLink IOL Edition is

funded by Bausch & Lomb (Rochester, New York) but isadministered independently by SurgiVision ConsultantsInc. Surgeons can enter data from any IOL intoDataLink. This article summarizes DataLink’s global dataon the Crystalens Five-O and Crystalens HD accommo-dating IOLs (Bausch & Lomb) and compares the resultswith these lenses to those of other presbyopia-correct-ing IOLs for key metrics.

As of April 2009, information on 41,538 eyes had beenentered into the DataLink IOL database, of which 5,319were implanted with the Crystalens HD. Of the HD eyes,3,104 had data entered through their 1-month postoper-ative examination. This analysis is based on 1-monthpostoperative data from the 97 surgeons who have re-ported on 10 or more HD eyes. Comparative data includ-ed the global data from the Crystalens Five-O, theAcrySof Restor nonaspheric diffractive multifocal IOL(the SN60D3), and the AcrySof IQ Restoraspheric IOL (SN6AD3; AlconLaboratories, Inc., Fort Worth, Texas).

REFRACTIVE PREDICTABILITYRefractive predictability was similar

across the IOL platforms. The meanspheroequivalent outcomes reflect themanufacturer’s targeting recommenda-tions, which is a positive confirmation ofthe performance of current biometricmethods. The results showed slightlynegative final refractions with theCrystalens Five-O and the Crystalens HDand slightly positive final refractionswith the AcrySof Restor IOLs (Figure 1).Standard deviations with all four lensesrange from 0.52 to 0.62 D. Most notably,

the predictability of the Crystalens HD is similar to thatof the Five-O.

STABILITYThe evaluation of the refractive stability of the IOLs

was based on a paired-visit analysis, which compares therefractions for each eye at 1 week and 3 months and thentallies the statistics. The results show that the meanrefractions tend to shift to some degree during this inter-val with all of the IOLs evaluated. Some shifted towardhyperopia and others toward myopia (Figure 2). The his-togram shows that although most of the lenses tend toshift positively, the Crystalens AT-45 and the AcrySof IQRestor IOL +3.0 D (SN6AD3) tend to shift negatively.The issue of the Crystalens HD’s postoperative refractive

DataLink measurements compared against multifocal IOLs.

BY GUY M. KEZIRIAN, MD


Figure 1. This graph shows refractive predictability between four presbyopia-

correcting IOLs (standard deviation, mean ±1).The predictability is similar

across all the lenses, and the data show that surgeons are achieving the recom-

mended targets for each implant.

“Binocular near acuity with the HD was

similar to that of the aspheric AcrySof

IQ Restor IOL +4.0 D.”



stability between 1 week and 3 monthshas been raised in the ASCRS chatrooms, and this analysis supports theclinicians’ impressions. On average, HDeyes experienced a slight myopic shift(0.21 D) between 1 week and 3 months.

Contrary to some clinicians’ impres-sions, the HD lens showed slightly betterrefractive stability than the Five-O. A com-parison of same-eye changes in refractionsbetween 1 week and 3 months showedthat the Five-O lens had slightly morescatter than the HD (0.08 ±0.88 D vs -0.21 ±0.62; Figure 3). Whereas the clini-cal impression of myopic shifts with theHD lens is accurate, it is probably ampli-fied by surgeons’ anticipation of a hyper-opic shift based on their experience withthe Five-O IOL.

Surgeons using presbyopia-correctingIOLs should anticipate this effect whenselecting IOL powers, and they shouldcounsel patients preoperatively thatthey may experience some variation intheir vision within the first 3 months.The data show that the refractions forall of the IOLs stabilized after 3 months,which suggests that routine refractiveenhancements can be performed atthat time.

VISUAL PERFORMANCE Figure 4 shows the average acuities at

distance, intermediate, and near forplano outcomes with the four lenses (theFive-O, the HD, the AcrySof RestorSN60D3, and the AcrySof Restor asphericSN6AD1). Average monocular distanceacuities were similar with all of the IOLs.The HD significantly outperformed theother lenses at intermediate distance.Crystalens HD near visual acuity wasslightly worse on a monocular basis, butbinocular near acuity with the HD wassimilar to that of the aspheric AcrySof IQRestor IOL +4.0 D.

The intermediate acuity with the HDlens shown here is remarkable, betterthan any previous reports to my knowl-edge. Intermediate vision is very impor-tant for the activities of daily living,


Figure 2. This graph shows the change in refractive stability from 1 week to 3

months with multiple presbyopia-correcting IOLs. Small refractive changes are

characteristic of most IOLs and are due to wound healing and changes in the

capsule in the early postoperative period.

Figure 3. This graph shows the paired analysis of refractive change between the

Crystalens Five-O and Crystalens HD IOLs from 1 week to 3 months.The majority

of eyes showed no significant changes in their refraction.The Crystalens HD

showed slightly better stability than the Crystalens Five-O.

Figure 4. This visual-performance profile of two Crystalens IOLs and two

AcrySof Restor IOLs shows the mean UCVA at all distances in eyes with plano

outcomes and no posterior capsular opacification.



such as reading computer screens, seeing the dashboard,and looking across a dining table. The mean intermediateacuity with the Crystalens HD lens in this series was bet-ter than 20/20 (Figure 5).

A comparison of BSCVA shows that the CrystalensHD’s BCVA at 3 months averages about 20/20 (Figure 6),which was slightly better than with the other lenses.

DEFOCUS CURVESDefocus curves plot visual acuity against refractive

errors and allow surgeons to understand the impact ofrefractive errors on visual acuity. The defocus curves ofIOLs (accommodating and multifocal) differ greatly fromplatform to platform and are influenced by lens optics,pupillary size, and other variables.

Defocus curves generated using pooled data candescribe the average performance of the various IOLs.For this analysis, defocus curves were generated usingdata from eyes entered into DataLink. To be included,data from at least 10 eyes at each refractive interval wererequired.

Figure 6A shows the defocus curve for distance, inter-mediate, and near visual acuities with the Crystalens HD.In this graph, only eyes with very little or no cylinder (upto 0.50 D) were included to demonstrate the effect ofspherical defocus on vision. The distance plot shows thatdistance vision decreases with any amount of myopiawith the HD lens. In other words, the HD lens is sensitiveto myopic refractive errors. Conversely, distance visualacuity was maintained with the HD lens with moderateamounts of hyperopia due to its accommodative effect.In terms of intermediate acuity, the HD performs wellover a range of refractive errors, as noted earlier. Nearacuity is optimal with approximately 0.50 D of myopia.

Figure 6B shows the impact of cylinder on vision over

the same refractive range. These plots were created usingeyes with 0.75 to 1.50 D of postoperative astigmatism overthe same spheroequivalent range as in Figure 6A. All of thecurves are shifted upward, demonstrating the negativeimpact of postoperative astigmatism on visual perform-ance. The importance of postoperative astigmatism hasoften been overlooked—these plots emphasize the im-portance of minimizing postoperative astigmatism withpresbyopia-correcting IOLs.

Prior use of myopic targets and inadequate attention topostoperative astigmatism may explain why some sur-geons report decreased distance vision with this lens.Based on this information, the optimal refractive outcomefor the HD lens is plano to slightly plus in the distance eyeand plano to slightly minus in the near eye, with minimalor no postoperative astigmatism. Given the average 0.21 Dmyopic shift that occurs with the HD lens, the surgeon’sselection of a lens should target a slightly hyperopic initialresult and anticipate a final outcome near plano.

OPTIMAL REFRACTIONSThis analysis underscores the need to optimize the

refractive outcome in order to take advantage of theCrystalens HD’s high-quality optics. Because this lens has

a flat wavefront (denoting a high-quali-ty optic), even small amounts of cylin-der of 0.75 to 1.50 D compromise itsperformance. Refractive errors causethe entire wavefront to move awayfrom the retina; conversely, accuraterefractive outcomes cause the entirewavefront to be in focus, resulting inexcellent visual quality and mesopicvisual function.

IOLs with multiple focal points arenot as severely affected by defocus,because their optics allow patients toselect whichever focal point is available.However, the quality of vision with theselenses is similarly reduced by refractive


Figure 5. This graph shows the mean BCVA at 3 months for eight IOLs in the

DataLink database.

“Based on this information, theoptimal refractive outcome for the HD

lens is plano to slightly plus in thedistance eye and plano to slightly

minus in the near eye, with minimal orno postoperative astigmatism.”



errors. Surgeons should strive to minimize postoperativerefractive errors with all premium IOLs. These opticalproducts rely on accurate refractive outcomes to delivertheir full benefit.

The optimal postoperative refraction for theCrystalens HD is slightly hyperopic for distance visionand slightly myopic for near vision. To evaluate the visualperformance when these targets are achieved, Figure 7shows binocular acuities in patients from the DataLinkdatabase who had plano to 0.25 D spheroequivalents intheir distance-corrected eye and -0.25 to -0.50 in their

near-corrected eye, with no posterior capsular opacifica-tion and cylinder of 0.25 D or less. The visual acuitieswere quite satisfactory at all distances.

LEAVE EVERY EYE IN FOCUS Surgeons should strive to leave every eye in focus.

Despite accurate targeting, factors such as limits on theaccuracy of biometry and healing issues will make it nec-essary to perform refractive enhancements on some eyesin order to deliver an optimal outcome with presbyopia-correcting IOLs.

Successful patient management begins with settingappropriate expectations preoperatively. Patients optingfor presbyopia-correcting IOLs expect spectacle-freevision at all distances. The defocus curves demonstratethat good refractive outcomes are needed to achievethis result. Patients should be advised before surgerythat they may need to undergo a refractive enhance-ment at 3 months to achieve the optimal outcome.Setting this expectation keeps patients from being disap-pointed if they need an enhancement and leaves themdelighted if they don’t. Either way, they will be satisfiedand will become your best source for new referrals. ■

Guy M. Kezirian, MD, is a board-certified ophthalmolo-gist. He is president of SurgiVision Consultants, Inc.(www.SurgiVision.net), an ophthalmic consulting and soft-ware company in Scottsdale, Arizona. Dr. Kezirian may bereached at tel: +1 480 664 1800; e-mail:[email protected].


Figure 6. (A) The Crystalens HD’s distance UCVA in eyes with little or no postoperative cylinder (0 to 0.50 D). Distance vision

decreases with any amount of myopia. Near vision is optimal at -0.50 to -1.00 D. (B) The Crystalens HD’s distance UCVA in eyes

with significant postoperative cylinder (0.75 to 1.50 D). Distance vision decreases with any amount of myopia. Near vision is

optimal at -0.50 to -1.00 D. Distance and near vision are significantly worsened by cylinder. Hyperopia abruptly decreases inter-

mediate visual acuity when cylinder is present.

A B

Figure 7. Current DataLink outcomes for the Crystalens HD in

patients whose refractions were plano to 0.25 D in their dis-

tance-corrected eye (n = 617) and -0.25 to -0.50 D in their

near-corrected eye (n = 715) and no posterior capsular opaci-

fication or cylinder.

Defocus Spheroequivalent (D)

Vis

ual

Acu

ity

(20/

x)

Vis

ual

Acu

ity

(20/

x)

Defocus Spheroequivalent (D)



Crystalens Clinical Keys

The traditional stereotype of an elderly, indif-ferent cataract patient whose visual acuity istargeted solely for distance is quickly beingreplaced by the new type of cataract patientwho is younger, more demanding, and wantsto have sharp vision and be spectacle free at

all distances. The latest-generation presbyopia-correctingIOLs are enabling us to meet these patients’ expectations,and I believe lenticular technology will continue to improve.The Crystalens accommodating IOL (Bausch & Lomb,Rochester, New York) is a great example of a lens that getsbetter with every generation. The improvement from theoriginal AT-45 to the current HD version is substantial, andthe technology will continue to evolve. Currently, I believethe Crystalens HD IOL is the only US Food and DrugAdministration (FDA)-approved accommodating presby-opia-correcting lens available.

When it comes to implanting refractive lenses, however, Ihave learned that there are no shortcuts. The following arethe keys to clinical success with presbyopia-correctingimplants that I have learned through experience.

KEY NO. 1: INCREASE REFR ACTIVEACCUR ACYOptimize IOL calculations. Patient happiness with theCrystalens HD is directly related to the postoperative refrac-tion: the closer it is to plano, the happier the patient.Because cataract surgery is a type of refractive surgery, it iscritical for us surgeons to hit our refractive tar-gets. Thus, we must track our results and honeour lens calculations and A-constants. Out-comes tracking can be done quite easily viaDataLink (SurgiVision Consultants Inc.,Scottsdale, Arizona), which is a simplified andfree software for tracking surgical data.

Target refractions. For the Crystalens HD, thedominant eye should be targeted toward slightpostoperative hyperopia, such as 0.25 D. Thisrefraction will give sharp distance vision, greatintermediate vision, and good near vision. Thenondominant eye can be targeted for a slightamount of residual myopia, such as -0.25 D, tofurther enhance the patient’s near vision.

Correct astigmatism and refractive error. Refractive accu-racy also means treating preoperative and induced astigma-tism. It is important for us to take preoperative topography,calculate the flattening effect of our incisions (most clearcorneal incisions flatten the cornea by approximately 0.50D), and to know how to use limbal relaxing incisions (LRIs)or an excimer laser for touch-ups. These steps are no longeroptions, but requirements.

The difference between a happy and an unhappyCrystalens HD patient may be the presence or lack of post-operative cylinder with the same spherical equivalent. Wehave to know how to fix postoperative surprises either onthe cornea (with LASIK or PRK) or via an intraocular tech-nique (with a piggyback IOL or an IOL exchange). Approx-imately 10% to 15% of patients need a postoperativeenhancement to optimize their refractive target. I explainthis rate to my patients by telling them that I can place theIOL in a perfect position within their eye, but I cannot pre-dict how their eye will heal. I also tell them that if theyrequire a postoperative touch-up, I will happily do whateverit takes to help them achieve their goal of sharp vision.

To implant the Crystalens HD in eyes that have under-gone prior refractive surgery, it is best to target myopia,since it facilitates a touch-up with PRK or LASIK. Start bydetermining the eye’s true keratometric power, and main-tain the patient’s monovision to prevent the lenticular re-fraction from interfering with his corneal refraction. The IOLcalculator on the ASCRS Web site (http://iol.ascrs.org/) is

Pearls I have learned from personal experience with the Crystalens accommodating IOL.

BY UDAY DEVGAN, MD


Figure 1. The full spectrum of refractive surgery.



my preferred online tool for performing IOL calculations forthese eyes. Remember, however, that all IOL calculations arejust estimates.

I prefer to use an excimer laser to perform enhance-ments after implanting a refractive IOL in a post-LASIK eye,which essentially is a bioptics approach to vision correction(Figure 1). For those who prefer to treat residual cylinderwith LRIs, several effective nomograms are helpful. TheDONO nomogram, devised by Eric Donnenfeld, MD, ofRockville Centre, New York, is one of the easiest to use. Ialso recommend the online nomogram available atwww.lricalculator.com. Generally, LRIs are best for treatingup to 1.50 D of residual astigmatism, and LASIK or PRK ispreferable for treating higher amounts.

For residual spherical error, if the patient’s refraction isclose to plano (20/20 or 20/30), do not enhance his vision. Ifhe has 20/40 myopic or hyperopic vision, determinewhether he prefers stronger vision at distance or near, andthen enhance his vision appropriately (Figure 2). I use LASIKand PRK to treat sphere in the midrange of 2.00 to -8.00 D,where it most often falls. For significant postoperativehyperopia, a piggybacked lens or a refractive lens exchangemay be the best option.

KEY NO. 2: DECREASE COMPLICATIONSTake any measures necessary to minimize complications,

either intra- or perioperatively. To decrease the risk of capsu-lar rupture, make sure that the fluidic settings on yourphaco machine are optimized to minimize surge. Thismeans keeping the inflow of fluid significantly higher thanthe outflow of fluid throughout the entire case. A soft, sili-cone-coated I/A tip is helpful as well.

I like to use NSAIDs for every patient to keep the maculapristine and to help control postoperative inflammation. I

use Xibrom (Ista Pharmaceuticals, Inc., Irvine, California)preoperatively for 3 days and then postoperatively for 6weeks to control inflammation, increase the patient’s com-fort, and decrease the risk of cystoid macular edema.

KEY No. 3: TUNE UP THE OCULAR SURFACEAND THE POSTERIOR CAPSULEA healthy ocular surface is paramount to achieving goodoutcomes with presbyopia-correcting lenses. Examine eyespreoperatively for any signs of blepharitis, epithelial mem-brane dystrophy, or other surface issues. When planningfor postoperative enhancements, keep in mind that LASIKperformed after a lenticular implantation can cause signifi-cant dry eye (and most presbyopic patients have dry eyesto begin with). Make sure to explain this risk to thepatient, or he will think that your surgery caused his oculardryness.

The clarity of the posterior capsule is also important tothe patient’s visual acuity. Make sure there are no striae pres-ent, and perform an Nd:YAG capsulotomy if needed. Avoidthe mistake of enhancing an eye with an excimer laser with-out first performing the capsulotomy. If the excimer en-hancement is done first, and months later the patient devel-ops a posterior capsule opacification, the Nd:YAG capsulo-tomy can change his refraction.

KEY NO. 4: MAKE A SPECIFIC IOLRECOMMENDATION FOR EACHPATIENT

Patients are coming to you for your expertadvice and guidance. I avoid giving patients along list of choices and then asking them topick one. For patients to choose the most suit-able lens requires them to become junior oph-thalmologists. Instead, we should evaluatepatients’ biometry and ocular health and theninterview them to determine which lenswould be best suited to their eyes and theirvisual needs.

For the average patient, I target 0.25 D inthe dominant eye and -0.50 D in the non-dominant one. I do not follow this rule for all


Figure 2. Postoperative enhancement strategies per residual refraction.

“To implant the Crystalens HD in eyes

that have undergone prior refractive

surgery, it is best to target myopia.”



patients, however. For example, I may target -0.75 D inboth eyes of a low myope who hates monovision, wants tobe able to read uncorrected, and does not mind wearingglasses for driving. For younger and more demandingpatients, I target a little more myopia, 0.25 D in the domi-nant eye and -0.75 D in the nondominant one, tostrengthen their reading ability. Even monocular patients

see well with the Crystalens HD; for them, Itarget 0.25 D.

KEY NO. 5: EXCEED THEIREXPECTATIONS

Find out what your patient wants. Patientsurveys, such as the one created by StevenDell, MD, of Austin, Texas (Figure 3), areextremely useful for determining the patient’svisual goals. Also, be wary of patients withunrealistic expectations and a sense of entitle-ment. No matter how hard we try, we cannotgive patients the fountain of youth. I tell them,“You will see better, but not like you did whenyou were 21 years old.” You have heard itbefore, but underpromising and overdeliveringis a reliable strategy. I highly recommend givingpatients the Crystalens Near Acuity Cardbefore surgery (Figure 4). Have them circle and

initial the last line they can read on the card, then ask themto repeat this exercise after the surgery. It is an effective toolto show them how much their vision has improved. Finally,stress to patients that their vision will improve with time.

I also try to set patients’ expectations for the quality ofvision they can reasonably expect after surgery. I tell themthat driving, working at a computer, using a cell phone, andreading the newspaper in good light are all activities theycan reasonably expect to perform without glasses afterimplantation with the Crystalens HD. Reading the nutritioninfo on the back of a packet of Splenda by candlelight in adimly lit restaurant is not a reasonable expectation.

SUMMARYWith the Crystalens HD, we have the ability to help our

cataract patients recover a wide range of high-quality visionwhile minimizing their dependence on spectacles. We needto leave every eye in focus by achieving a plano result withminimal astigmatism, and we must minimize any complica-tions that could adversely affect a patient’s vision. Mostimportantly, we need to educate our patients so that theyknow what to expect after surgery. ■

Uday Devgan, MD, is in private practice in Los Angeles andBeverly Hills, California. He is also the chief of ophthalmologyat Olive View UCLA Medical Center and an associate clinicalprofessor at the UCLA School of Medicine. He is a consultant toBausch & Lomb, Abbott Medical Optics Inc., and IstaPharmaceuticals, Inc., but he acknowledged no financial inter-est in the products or companies mentioned herein. Dr. Devganmay be reached at tel: +1 310 208 3937; e-mail:[email protected]; Web: www.UdayDevgan.com.


Figure 3. Patient surveys help determine what the patient wants in terms

of visual performance.

Figure 4. The Crystalens Near Acuity Card for near vision.




HD Optics: Myths and Facts

A number of myths about the Crystalensaccommodating IOL (Bausch & Lomb,Rochester, New York) have arisen over theyears, and my goal is to review and dispelthem. I credit the Crystalens data on DataLink(SurgiVision Consultants Inc., Scottsdale,

Arizona) with dispelling many of these myths.

MYTH NO. 1: THE CRYSTALENS HD IS AMULTIFOCAL IOL

Fact: The Crystalens HD has a blended bispheric opticthat generates a single point of focus. The center of theoptic includes a 1.5-mm—diameter modification that adds3 µm of thickness and provides a small degree of negativespherical aberration (Figure 1). This negative spherical aber-ration is very important to the refractive endpoint of thelens. Its purpose is to maximize the reading vision duringthe Crystalens’ process of accommodative arching, whichclosely mimics the action of the natural crystalline lens.

The Crystalens HD has a sharper point of focus than theCrystalens AT-45 (RMS 0.36 vs 0.57, respectively). Also, theCrystalens HD and AT-50 achieve greater contrast sensitivityand visual acuity than three current multifocal IOLs (Figure2). Multifocal lenses simply cannot have MTF curves thatcompare with those of the Crystalens.

MYTH NO. 2: THE CRYSTALENS CAUSESSYMPTOMS OF DYSPHOTOPSIA

Fact: The Crystalens HD causes no more glare and halosthan the AT-50 or any other monofocal IOL. Unfortunately,misinformed fear is keeping many surgeons from tryingwhat I consider to be the best optic currently available. Thecontrast sensitivity function between the Crystalens HD andthe AT-45 is very similar. The HD’s modified optic does notbreak up the light or the point of focus; rather, it flattens thewavefront curve and provides more perfect optics.

MYTH NO. 3: THE CRYSTALENS IS NOT PREDICTABLE

Fact: The Crystalens HD is just as predictable as the pre-vious generation of the lens. Patients, however, are moresensitive to defocus with the HD. Although the HD’s stan-dard deviation is very much in line with that of other lenses(see page 7), its defocus curves may be slightly worse. Again,

this is due to the lens’ aspheric, single point of focus, whichstrengthens the quality of the optics and makes them sus-ceptible to even small amounts of cylinder. Thus, CrystalensHD patients with as little as 0.50 D of astigmatism or spheremay be symptomatic.

Proper wound formation and closure helps to minimizeastigmatism. A square wound is preferable, because it is lesslikely to leak than straight wounds. Further, I encourage cat-aract surgeons to perform Seidel tests after every surgery,which will show whether a wound is leaking or sealed (Figure3). If you see even a small leak after implanting a Crystalens,you should suture it to minimize the astigmatism.

Data-driven truths about the Crystalens accommodating IOL.

BY JOHN A. HOVANESIAN, MD

Figure 2. An MTF comparison of the Crystalens AT-50SE, the

Crystalens HD100, the ReZoom (Abbott Medical Optics Inc.,

Santa Ana, California), the AcrySof Restor nonaspheric

aspheric IOLs (Alcon Laboratories, Inc., Fort Worth,Texas).

Figure 1. The Crystalens HD aspheric IOL has a 1.5-mm–diam-

eter central modification that increases its thickness by 3 µm.

(Courtesy of Jack Singer,MD)




I conducted a study of 50 eyes with wound leaks and50 eyes without leaks after implantation of the CrystalensFive-O.1 I found a significant difference between the finalrefractions of the two groups (-0.44 vs 1.0, respectively).Positive Seidel wounds correlate with the Crystalens’shifting myopically by a mean of 0.54 D (P=.023). Manysurgeons are now suturing after every Crystalens implan-tation to ensure against any wound leakage.

MYTH NO. 4: THE CRYSTALENS CANNOTGIVE ADEQUATE NEAR VISION

Fact: DataLink figures and the FDA studies confirmthat, compared with the Crystalens Five-O, HD patientsgain one line of near UCVA without losing distanceUCVA. Figure 4 shows a marked improvement in monoc-ular distance-corrected near visual acuity with each gener-ation of the Crystalens. Ninety percent of HD patientsachieve J3 or better vision by 4 to 6 months postopera-tively. As Guy M. Kezirian, MD, has described, CrystalensHD patients whose final refractions are on target (withtheir distance eye set from plano to +0.25 D and their

near eye set to -0.25 to -0.50 D) are uniformly happy.These patients’ total visual acuity is impressive, rangingfrom 20/20 at distance to 20/25 at near.

SUMMARYThe Crystalens HD is a highly predictable lens that pro-

vides presbyopic patients with excellent quality and quanti-ty of vision. As long as surgeons optimize the target refrac-tion, they will easily build a referral practice of patients ask-ing for the Crystalens HD. ■

John A. Hovanesian, MD, is in private practice at HarvardEye Associates in Laguna Beach, California. He is also a clinicalinstructor at the UCLA Jules Stein Institute. He is a paid consult-ant to Bausch & Lomb. Dr. Hovanesian may be reached at tel:+1 949 951 2020; e-mail: [email protected].

1. Hovanesian JA.Small wound leaks are associated with myopic surprises in cataract surgery.Poster presented at:The AAOAnnual Meeting.November 8-11,2008;Atlanta,GA.

Figure 4. Monocular distance-corrected near visual acuity

within ±0.50 D of the intended target refraction in 60 eyes 4

to 6 months postoperatively.

Figure 3. Yellow dye shows a leak in a clear corneal incision.

Crystalens’ vaulting via ultrasound on postoperative day 1. Guard against implanting the lens upside down by checkingthat the leading haptic curves to the right.

8. Aggressive control of astigmatism. Become an astig-matic fanatic. I treat corneal astigmatism as low as 0.50 D ker-atometrically at the time of surgery. I use the Gills nomogram(http://www.stlukeseye.com/professionals/lri_nomogram.htm), because it is simple to use. I also employ aDell corneal marker (Rhein Medical Inc., Tampa, Florida).

9. Employ therapeutics long term. It is imperative toavoid cystoid macular edema, inflammation, and capsularcontraction in refractive IOL patients. I prescribe patientssteroidal and NSAID drops q.i.d. for 2 weeks and then b.i.d.for 8 weeks postoperatively. The blood-aqueous barrier does

not restabilize for 8 to 10 weeks after surgery.

10. Have an enhancement strategy. I will perform a refractivelens exchange for an incorrect power no later than 6 weeks postoperatively. I will not perform any Nd:YAG laser pro-cedures before 12 weeks postoperatively, because the contractiveforces on the capsule and the blood-aqueous barrier have notrestabilized. Do not perform a laser vision correction beforedoing a Nd:YAG laser capsulotomy, because the laser may solvethe issue. Finally, I recommend finishing the job refractively everytime, and leaving the eye alone once the patient is 20/happy. ■

Harvey L. Carter, MD, is Director of the Carter Eye Center, inDallas. He is a paid consultant for Bausch & Lomb. Dr. Cartermay be reached at tel: +1 214 775 1275; e-mail:[email protected].

TOP TEN HABITS OF THE SUCCE SSFUL CRYSTALEN S SURGEON

(Continued from page 6)


SU5709


Documents

Form and Function: The Crystalens HDcrstodayeurope.com/wp-content/themes/crste/assets/... · 14 HD OPTICS: MYTHS AND FACTS Data-driven truths about the Crystalens accommodating IOL